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PURPOSE. To identify genetic variants conferring susceptibility to esotropia. Esotropia is the
most common form of comitant strabismus, has its highest incidence in European ancestry
populations, and is believed to be inherited as a complex trait.
METHODS. White European American discovery cohorts with nonaccommodative (826 cases
and 2991 controls) or accommodative (224 cases and 749 controls) esotropia were
investigated. White European Australian and United Kingdom cohorts with nonaccommoda-
tive (689 cases and 1448 controls) or accommodative (66 cases and 264 controls) esotropia
were tested for replication. We performed a genome-wide case–control association study
using a mixed linear additive model. Meta-analyses of discovery and replication cohorts were
then conducted.
RESULTS. A significant association with nonaccommodative esotropia was discovered (odds
ratio [OR] ¼ 1.41, P ¼ 2.84 3 1009) and replicated (OR ¼ 1.23, P ¼ 0.01) at rs2244352 [T]
located within intron 1 of the WRB (tryptophan rich basic protein) gene on chromosome 21
(meta-analysis OR ¼ 1.33, P ¼ 9.58 3 1011). This single nucleotide polymorphism (SNP) is
differentially methylated, and there is a statistically significant skew toward paternal
inheritance in the discovery cohort. Meta-analysis of the accommodative discovery and
replication cohorts identified an association with rs912759 [T] (OR ¼ 0.59, P ¼ 1.89 3
1008), an intergenic SNP on chromosome 1p31.1.
CONCLUSIONS. This is the first genome-wide association study (GWAS) to identify significant
associations in esotropia and suggests a parent-of-origin effect. Additional cohorts will permit
replication and extension of these findings. Future studies of rs2244352 and WRB should
provide insight into pathophysiological mechanisms underlying comitant strabismus.
Keywords: strabismus, esotropia, parent-of-origin, genome-wide association study, WRB
Strabismus is the pathological misalignment of the eyes andaffects up to 4% of the population. All but a few percent of
cases of strabismus are comitant, in which the angle of
misalignment between the two eyes remains relatively
constant with changes in gaze direction.1,2 Most individuals
with comitant strabismus have esotropia (ET, inward eye
deviation) or exotropia (XT, outward eye deviation). The
prevalence of ET is ~2.5% among White populations of
European ancestry and 0.5% among Africans and Asians. By
contrast, XT has a prevalence of ~1% among Africans, African
Americans, and White populations of European ancestry, and is
only slightly higher (~1.2%) among Asians.3
Comitant strabismus is associated with poor binocular
vision and amblyopia (uniocular visual neglect), and individu-
als with amblyopia have a much higher lifetime risk of bilateral
visual impairment.4 Comitant strabismus can also disturb
normal interpersonal interactions, resulting in poor self-
esteem, social anxiety, phobias,5,6 and limited employment
options,7 leading to subtle but pervasive losses of productivity
in the population.8 While glasses and surgery are standard
treatments for comitant strabismus, many patients will require
more than one procedure over a lifetime.9,10 The pathogenesis
of comitant strabismus remains largely unknown, and while
opposing theories relevant to the infantile form of ET have long
been debated,11–15 they remain unproven.
There is a significant heritable component to comitant
strabismus, and familial clustering was described as early as
approximately 400 BCE by Hippocrates.16 Subsequent family-
based and twin studies have supported a genetic contribu-
tion,17–20 with the relative risk for first-degree relatives of a
comitant strabismus-affected proband estimated to fall be-
tween 3 and 5.19,21 Moreover, heritability remains significant
following correction for environmental risk factors.22,23
Despite a clear genetic contribution to comitant strabismus,
there are limited data supporting Mendelian segregation.
Linkage analysis of two White pedigrees of European ancestry,
one with unspecified comitant strabismus and one with ET, led
to reports of linkage to chromosome 7p22.1 (STBMS1 locus,
Online Mendelian Inheritance in Man [OMIM]185100) under a
recessive24 and a dominant25 inheritance model, respectively.
A third study combined small Japanese ET and XT pedigrees
and reported genetic loci on chromosomes 4q28.3 and 7q31.2,
with stronger significance under a parent-of-origin linkage
model,26,27 and suggested that MGST2 and WNT2 are potential
candidates.28 Beyond this, the genetic contributions to
comitant strabismus remain undefined. This is in contrast to
the rare forms of congenital incomitant strabismus in which
ocular misalignment is associated with an angle of deviation
that changes in different directions of gaze; these are often
inherited as Mendelian traits and can result from gene
mutations that perturb ocular motor neuron and axon
development, resulting in primary malfunction in the ocular
motor output pathways.29–32
Given the high prevalence, significant morbidity, and
familial clustering of comitant strabismus, and data supporting
ET as a complex trait, we conducted a genome-wide
association study (GWAS) of ET in participants of White
European ancestry as a first step to define its genetic
architecture and unravel its pathogenesis.
SUBJECTS AND METHODS
The study was approved by the local Institutional Review
Boards of Boston Children s Hospital (Boston, MA, USA), The
Cleveland Clinic (Cleveland, OH, USA), the National Research
Ethics Service (Leicestershire, Northamptonshire, UK), the
Rutland Research Ethics Committee (Leicestershire, North-
amptonshire, UK), and the Human Research Ethics Commit-
tee, Royal Victorian Eye and Ear Hospital (East Melbourne,
Victoria, Australia), Princess Margaret Hospital (Perth, West-
ern Australia), and the Sir Charles Gairdner Hospital (Perth,
Western Australia, Australia). All investigations were conduct-
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ed in accordance with the principles of the Declaration of
Helsinki.
Inclusion Criteria
Inclusion criteria for study of nonaccommodative ET required
one of the following: (1) manifest or intermittent nonaccom-
modative ET of any size; (2) manifest or intermittent partially
accommodative ET of any size; (3) esophoria ‡ 10 prism
diopters; or (4) status post surgery for comitant ET. Inclusion
criteria for study of accommodative ET required manifest ET
that reduced with hyperopic correction (with or without
bifocals) to a range such that fusion may be achieved (<10
prism diopters) or be reliably demonstrated. Inclusion for the
purpose of testing association among individuals with ambly-
opia or hyperopia (independent of whether the ET was
accommodative or nonaccommodative) required: (1) for
amblyopia, a two or more line difference in best-corrected
visual acuity between the two eyes, or a strong fixation
preference in those unable to perform recognition acuity at
time of first examination, or a record of diagnosis of or
management for amblyopia; (2) for hyperopia, a refractive error
of ‡þ3.50 diopters in either eye at any age. Definitions of ET
subtypes are provided in Supplementary Methods.
Exclusion Criteria
Exclusion criteria for any of the studies included (1) structural
ocular abnormality causing acquired vision loss; (2) structural
brain abnormality as determined by neuroimaging (normal
neuroimaging was documented in 82 cases within the
discovery cohort and 4 cases within the replication cohort);
(3) conditions causing occlusion of the eye and leading to
deprivation amblyopia; (4) molecularly defined genetic syn-
dromes or other diagnoses associated with strabismus such as
trisomy 21 or craniosynostosis; (5) consecutive ET; (6) other
defined nonheritable etiology of strabismus.
Phenotyping
Phenotyping was based on a combination of (1) participant
examinations by an ophthalmologist, optometrist, or an
orthoptist with the exception of 148 participants who were
enrolled based on documentation of ET surgery, (2) participant
questionnaires, and (3) review of additional medical records
when available.
Discovery Cohort Cases
A total of 1174 participants who self-reported as White of
European ancestry were enrolled into the discovery cohort:
1105 from Boston Children’s Hospital, 52 from Cole Eye
Institute (Cleveland Clinic), 5 from Children’s Hospital of
Philadelphia, and 12 self-referred. After quality control (QC)
procedures the total number of participants in the discovery
cohorts was 1050 (Supplementary Table S1).
Replication Cohort Cases
A total of 856 participants who self-reported as White of
European ancestry were enrolled into the replication cohort:
745 from private ophthalmologists and public hospitals in New
South Wales, Western Australia, Victoria, and Tasmania,
Australia; 111 from Leicester, Devon and Bradford Hospitals,
Leicester, United Kingdom. After QC procedures the total
number of participants in the replication cohorts was 755
(Supplementary Table S1).
Controls
Control genotypes generated on Illumina SNP microarrays
were derived from the database of Genotypes and Phenotypes
(dbGaP) (Supplementary Table S1; Supplementary Methods).
Genotyping and Imputation
Discovery and replication cohorts were genotyped on
Illumina Infinium Human OmniExpress_24v1-0 array (San
Diego, CA, USA). dbGaP control cohorts had been genotyped
on Omni 2.5 Versions 4v_1H and 4v_1D arrays with the
exception of the eMERGE cohort, which had been genotyped
on OmniExpress Version 12-v1_c. The OmniExpress platform
used for genotyping cases was well represented on the larger
panels on which the controls were genotyped, and genotypes
from the discovery, replication, and control cohorts under-
went rigorous QC measures. The genotypes were then
merged, providing data for 337,204 single nucleotide poly-
morphisms (SNPs) in common among the two discovery
cohorts, two replication cohorts, and ancestry-matched
controls. Only cases and controls passing the QC measures
(Supplementary Fig. S1; Supplementary Methods) were
included in the final association tests. The SNPs overlapping
between all platforms were used as input for imputation
against 1000 Genomes phase I integrated variant set release
(v3) European samples (provided in the public domain by the
Center of Statistical Genetics, http://csg.sph.umich.edu//abe
casis/MaCH/download/1000G.2012-03-14.html). A total of
14,882,799 SNPs were successfully imputed using IMPUTE2
program (version 2) (available in the public domain, https://
mathgen.stats.ox.ac.uk/impute/impute_v2).33 Of these,
6,470,615 imputed SNPs with information metric > 0.3 and
minor allele frequency (MAF) > 0.01 were used. Notably, QC
measures, including differential missingness testing, control–
control associations, simultaneous imputation of cases and
controls, and calculation of genomic inflation lambda (k ¼
1.01), were conducted, in part, to limit the possibility of false-
positive results that could stem from genotyping of cases and
controls separately (see Supplementary Methods for details).
Genetic Association and Meta-Analysis
Following QC, statistical tests for association were carried out
in the discovery and then in the replication cohort using the
SVS suite (Golden Helix, Bozeman, MT, USA). Single marker
analyses for the genome-wide data were carried out using
mixed linear additive model. We used EMMAX method
(Efficient Mixed-Model Association eXpedited),34 incorporating
a precomputed kinship matrix, to account for known
relatedness, as a random effect and the first three principal
components as covariates. X chromosome SNPs were first
analyzed separately in males and females and subsequently
combined by meta-analysis. Because we used publicly available
controls from dbGaP and hence some of the controls might
have strabismus, we corrected for the association tests’ results
assuming a prevalence of 2% in control data. In addition, we
repeated the statistical tests using an independent set of
control individuals from the Health and Retirement control
cohort. The SNPs that had significant or suggestive levels of
association initially were comparable to the results using the
new control set, indicating that our findings do not represent
an artifact resulting from the use of historic controls.
Manhattan and quantile-quantile (Q-Q) plots were generated
with SVS suite, cluster plots were generated by Genome-Studio
Software (Illumina, San Diego, CA, USA), and regional
association plots were generated with LocusZoom (provided
in the public domain by University of Michigan, http://lo
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cuszoom.sph.umich.edu/locuszoom/).35 SNPs reaching signifi-
cant or suggestive levels of association in the discovery cohort
were checked in the replication cohort. In addition, we
performed meta-analysis between the discovery cohort and the
replication cohort using SVS suite. We performed both fixed-
effects (inverse-variance–based approach using the effect size
for the risk alleles and standard errors) and random-effect meta-
analyses by calculating the random-effects variance compo-
nent. The presence of heterogeneity between the two cohorts
was investigated using the I2 statistic. We also investigated our
association data for potential replication of previously reported
GWAS hits identified for ocular phoria.36 Lastly, we confirmed
the genotypes at the significantly associated SNP (rs2244352)
by genotyping 15 US cases, 9 cases from Australia, and 6 cases
from the United Kingdom (that were part of the cases included
in the GWAS) using Sanger sequencing.
Analysis and Functional Prediction of rs2244352
To evaluate the potential functional consequences of SNP
rs2244352, we first used GTEx (The Genotype-Tissue
Expression [GTEx] project) portal to investigate if it acts as
an expression quantitative trait locus (eQTL) in different body
tissues as well as in different regions of the brain (provided in
the public domain by The Broad Institute of MIT and Harvard,
http://www.gtexportal.org/).37 We also used the Regulome
DB (provided in the public domain by Stanford University,
http://www.regulomedb.org/),38 which compiles eQTLs,
ChIP-seq, and DNase-seq data from the ENCODE (Encyclope-
dia of DNA Elements) project,39 the Roadmap Epigenomics
Mapping Consortium40 and HaploReg v4.1 (provided in the
public domain by the Broad Institute, http://compbio.mit.
edu/HaploReg)41 to predict the possible function of
rs2244352 as well as those of other SNPs in linkage
disequilibrium. Potential chromatin interactions between
the genomic region containing rs2244352 and its neighboring
regions were investigated using published Hi-C chromatin
interactions.42
To investigate if a parent-of-origin effect of the rs2244352
[T] allele among the nonaccommodative ET discovery cohort
exists, we identified probands heterozygous for the [T] allele
for whom parental DNA was available (202 informative trios),
and genotyped the parents at rs2244352 using a Taqman assay
(Life Technologies, Carlsbad, CA, USA). We compared the
parental inheritance pattern at rs2244352 to those of 408
informative trios from unrelated syndromic cranial dysinnerva-
tion disorder and structural heart birth defect cohorts that
underwent whole genome sequencing through the Gabriella
Miller Kids First Pediatric Research Program. Unfortunately,
parental DNA was not available from parents of the replication
cohort.
RESULTS
Discovery and Replication Cohorts
A total of 2030 individuals diagnosed with comitant ET and self-
reported to be White of European ancestry were enrolled
(1052 females and 978 males, 2–91 years of age); 1174 from
the United States served as the initial cohort for discovery and
856 from Australia and the United Kingdom served as the initial
cohort for replication prior to QC procedures. Hypothesizing
that accommodative and nonaccommodative forms of ET have
different underlying etiologies, participants were divided into
two subgroups: the ‘‘nonaccommodative ET’’ group, and the
‘‘accommodative ET’’ group (see Subjects and Methods
section).
Genome-Wide Association Results
The nonaccommodative ET discovery cohort included 826
cases from the United States and 2991 controls from the
Genetic Variation in Refractive Error Substudy of the National
Eye Institute Age-Related Eye Disease Study (AREDS) and the
Health and Retirement Study (HRS). SNP rs2244352 [T] (the
minor [T] allele is also the reference allele) reached genome-
wide significance in the nonaccommodative discovery cohort
with P¼ 2.843 1009 (Fig. 1; Table), generating an odds ratio
(OR) of 1.41 assuming a 2% prevalence of ET in the control
population. The quantile-quantile (Q-Q) plot for the non-
accommodative ET GWAS is shown in Supplementary Figure
S2 and the cluster plot of rs2244352 is shown in Supplemen-
tary Figure S3.
We investigated the association of the 105 autosomal SNPs
that reached P  1 3 105 (including rs2244352) in the
nonaccommodative ET discovery cohort in a replication cohort
composed of 689 cases from the United Kingdom and Australia
and 1448 controls from a subset of the Fuchs’ Endothelial
Corneal Dystrophy (FECD) cohort. SNP rs2244352 showed
evidence of replication (P ¼ 0.006, OR ¼ 1.23) (Table;
Supplementary Table S2). Of note, rs2244352 was a genotyped
variant and there were no missing calls in cases and controls in
the discovery or replication cohorts. We then conducted a
meta-analysis of the association results between the non-
accommodative ET discovery and replication cohorts; the
meta-analysis P value at rs2244352 was 9.5831011, OR¼1.33
(Table). Finally, given that the nonaccommodative cohort was
heterogeneous, we tested whether any of the three largest
subtypes (manifest, intermittent, and infantile ET) drove the
association signal at rs2244352. P values at rs2244352 were
3.11 3 106 for manifest ET alone, 8.17 3 108 when
intermittent and manifest ET were combined, and 3.23 3
107 when infantile and manifest ET were combined, despite
the infantile ET cohort being larger than the intermittent
(Supplementary Table S1). This suggests that intermittent ET
was a stronger driver than infantile ET in our cohort.
To test for associations with accommodative ET, the
discovery cohort included 224 cases from the United States
and 749 controls from the HRS that did not overlap with the
nonaccommodative controls. SNP rs912759 [T], an intergenic
variant located within a ~2.3-Mb gene desert on chromosome
1, was the most significant, with P ¼ 6.533 1007, OR ¼ 0.59
(Supplementary Table S3). rs912759 was a genotyped variant
and there were no missing calls in cases and controls in the
discovery or replication cohorts. The Q-Q plot for the
accommodative GWAS, the cluster plot, and regional associa-
tion results for rs912759 are shown in Supplementary Figures
S2, S3, and S4, respectively. We investigated the top SNPs from
the accommodative ET discovery cohort (P  1 3 1005) in a
replication cohort of 66 cases from Australia and the United
Kingdom and 264 controls from the eMERGE cohort (Supple-
mentary Table S1). The discovery association results for
rs912759 replicated (P ¼ 0.008, OR ¼ 0.59) with consistent
effect size and direction. When meta-analysis of the combined
accommodative ET cohorts was conducted, rs912759 exceed-
ed genome-wide significance (overall P ¼ 1.89 3 1008, OR ¼
0.59) (Supplementary Table S3; Supplementary Fig. S4).
Although we hypothesize that accommodative and non-
accommodative ET do not have the same genetic etiology, we
assumed that some loci might overlap and hence we combined
both cohorts in a meta-analysis, which maximized our overall
sample size. The meta-analysis did not reveal any new
significant associations and reduced the significance and
increased the heterogeneity at the loci with significant
associations: rs2244352, the SNP associated with nonaccom-
modative ET, had an overall fixed effect P ¼ 2.07 3 1010,
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random effect P¼1.731005, and I2 statistic¼0.31; rs912759,
the SNP associated with accommodative ET, had an overall
fixed effect P¼ 0.0077, random effect P¼ 0.079 and I2 statistic
¼ 0.88. Supplementary Table S4 compares the results at
rs2244352 and rs912759 between the accommodative and
nonaccommodative ET cohorts.
We also investigated whether specific associations existed
for amblyopia or hyperopia within our discovery and
replication cohorts, independent of whether the ET was
accommodative or nonaccommodative. For amblyopia, we
identified and analyzed data from 386 and 45 cases within the
discovery and replication cohorts, respectively, matched to
1700 and 180 controls. Neither the primary association test in
the discovery cohort nor the meta-analysis identified SNPs that
reached statistical significance (Supplementary Table S5). For
hyperopia, we identified and analyzed data from 361 and 172
cases within the discovery and replication cohorts, respective-
ly, matched to 1700 and 690 controls. Again, no SNP in the
primary or meta-analysis showed significant association (P < 5
3 108) (Supplementary Table S5). We did not replicate the
associations on chromosome 15q14 or 8q12 reported for
hyperopia, perhaps because our cohort was much smaller than
in the original study.43 We were also underpowered to test for
specific associations with ocular phoria, but we did not find an
association with the recently reported locus on chromosome
6p2236 for any of the phenotypes we tested in the current
study.
Functional Assessment of Significantly Associated
Variants
rs2244352, associated with nonaccommodative ET, is located
within DNase hypersensitivity clusters in multiple tissues,
including fetal brain.39 DNA footprinting and Chip-Seq
experiments predict that the [T] allele alters the sequence of
several regulatory motifs (Fig. 2A), and the binding of POLR2A,
TAF1, NRF1, E2F1, and USF1 transcription factors in a variety
of cell lines.39,44 Moreover, interrogation of Hi-C chromatin
interaction data45 reveals that WRB (within which rs2244352
resides) and other eQTL genes in the region (LCA5L, SH3BGR,
HMNG1, and BRWD1) fall within the boundaries of a
topologically activated domain (TAD) (Fig. 2B).
FIGURE 1. Association results of the nonaccommodative esotropia discovery cohort. (A) Manhattan plot of association results from the discovery
data for the nonaccommodative esotropia cohort. The y-axis represents the log10 (P values). The bolded upper horizontal line indicates the
threshold for genome-wide significance (P < 53 108) and the lower line indicates the threshold for suggestive association (P < 13 105). The
SNP rs2244352 had a P¼ 2.843 109. (B) Regional association plot from the discovery nonaccommodative esotropia cohort. The top-ranked SNP,
rs2244352, is shown as a solid purple diamond. The color scheme indicates linkage disequilibrium between rs2244352 and other SNPs in the
region using the r2 value calculated from the 1000 Genomes project. The y-axis is thelog10 (P value) computed for the displayed SNPs.
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rs2244352 was assigned the score [1b] in the Regulome
Database. This is the second highest of 14 possible scores
supporting a functional role for a SNP, and is the highest score
assigned to any SNPs in WRB, LCA5L, and SH3BGR, the genes
with which rs2244352 is in high linkage disequilibrium (LD)
(Supplementary Table S6). We interrogated the GTEx portal46
to investigate if the rs2244352 risk allele [T] acted as an eQTL
in different body tissues. The rs2244352 risk allele [T]
correlates largely with increased expression of WRB, LCA5L,
SH3BGR, and BRWD1 in multiple tissues (Supplementary
Table S7). We specifically investigated if rs2244352 [T] affects
expression of WRB or other genes within regions of the brain
for which GTEx has data. Similar to findings in nonbrain
tissues, rs2244352 [T] increases the expression of WRB,
LCA5L, and SH3BGR in all brain regions examined with the
exception of the frontal cortex, where WRB expression is
noted to be decreased. By contrast, HMGN1 and PSMG1
expression is decreased (Fig. 3; Supplementary Tables S7, S8).
Finally, the nongenic variant rs912759, which is associated
with accommodative ET in the meta-analysis, is predicted by
HaploReg v4.141 to alter the regulatory motifs for Nkx3_5,
Nkx2_11, Hbp1, and HMG-IY_2, but there are currently no
data to support its action as an eQTL.
Testing the Parent-of-Origin Effect for rs2244352
rs2244352 is located 73 base pairs 30 to CGI-2, one of multiple
5mCpG islands within WRB (CGI-2; Chr21: 40757603-
40757900). Although CGI-2, -3, and -5 are differentially
methylated, only CGI-2 is located within the differentially
methylated region (DMR) for which WRB was classified as a
candidate maternally imprinted gene.47–49 Several studies have
reported a correlation between increased maternal methyla-
tion of WRB CpG islands and decreased WRB expression in
select tissues,48,50 while others have found biallelic expression
of WRB and its neighboring genes, suggesting that the maternal
imprinting of WRB is isoform- and/or tissue-specific.48,49 Thus,
we hypothesized that paternal inheritance of the unmethylated
at-risk rs2244352 [T] allele increases expression of WRB and/
or other target genes in the TAD and increases the risk of
nonaccommodative ET. To test this hypothesis, we asked if
there was a parent-of-origin effect of the rs2244352 [T] allele
among the nonaccommodative ET discovery cohort. We
identified probands from both the discovery and replication
cohorts who were heterozygous for the [T] allele and for
whom parental DNA was available, and genotyped the parents
at rs2244352 using a Taqman assay (Life Technologies). Of 202
informative trios (114 ET, 42 infantile ET, 44 intermittent ET,
and 2 acquired ET), 120 (59.4%) probands inherited the [T]
allele paternally and 82 (40.6%) inherited it maternally. This
paternal skew was significant (P¼ 0.023, v2) when compared
to 408 informative trios from unrelated birth defect cohorts, of
which 193 probands (47.3%) inherited the [T] allele paternally,
and 215 probands (52.7%) inherited it maternally. Thus, the OR
is 1.63 if the [T] allele is paternally inherited, and is 0.6 if
maternally inherited.
DISCUSSION
Using discovery cohorts from the United States and replication
cohorts from the United Kingdom and Australia, we report two
significantly associated SNPs on chromosomes 21 and 1 for
nonaccommodative and accommodative ET, respectively. We
chose the discovery, replication, and control cohorts from
Caucasian populations of European ancestry and conducted
principal component analysis to confirm absence of popula-
tion stratification. Because we used controls from the databaseT
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of Genotypes and Phenotypes (dbGaP), rigorous QC metrics
were taken to ensure that allele frequency differences were
reflective of true locus-specific associations and not the result
of differential genotype calling (batch effects) or population
stratification. The two significant SNPs (rs2244352 and
rs912759) were genotyped in both discovery and replication
cases and controls with no missing calls. Together, these
measures provide greater confidence in the discovery and
replication results.51
Our most significant association was with SNP rs2244352,
which we found to be associated with nonaccommodative ET.
rs2244352 falls at the midpoint of intron 1 of the WRB
(tryptophan rich basic protein) gene on chromosome 21. WRB
is the homolog of yeast Get1; it is located on the surface of the
FIGURE 2. DNA-footprinting prediction of the effect of the risk allele [T] on regulatory motifs and two-dimensional heatmap of chromatin
interaction in the neighborhood of SNP rs2244352. (A) DNA footprinting predicts that the [T] allele alters the sequence of c-Ets-1 and PU-1
regulatory motifs.38 Sequence logos were created by CENTIPEDE.38,44 (B) UCSC genome browser shot of chromosome 21 (NCBI Build 37; provided
in the public domain by University of California-Santa Cruz, https://genome.ucsc.edu/) created by 3D Genome Browser (provided in the public
domain by Pennsylvania State University, http://promoter.bx.psu.edu/hi-c)78 showing WRB and surrounding genes (PSMG1, BRWD1, HMGN1,
LCA5L, and SH3BGR) included within a topologically associating domain (TAD) as defined by chromatin conformation capture data (Hi-C profiles).
The two-dimensional heatmap represents normalized Hi-C interaction frequencies.
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endoplasmic reticulum (ER) and, together with calcium-
modulating ligand (CAML), forms a transmembrane receptor
complex that mediates the posttranslational TRC40-mediated
insertion of tail-anchored (TA) proteins into the ER mem-
brane.52–54 TA proteins have a single C-terminal transmembrane
domain that anchors them to a variety of organelles in both
secretory and endocytic pathways; they constitute 5% of total
membrane proteins and play critical roles in cell function.
Consistent with this, WRB is widely expressed in all fetal and
adult tissues examined.37,55 Wrb loss-of-function zebrafish
mutants are blind and deaf secondary to a reduction in synaptic
ribbons and surrounding vesicles in the sensory retina and hair
cells, and die by 10 days post fertilization.56,57 Mice with
conditional Wrb deletion in inner-ear sensory hair cells also have
fewer ribbon-associated vesicles, impaired hair cell exocytosis,
and hearing loss.58 By contrast to these Wrb loss-of-function
phenotypes, our data support the contribution of increased
WRB expression to susceptibility to nonaccommodative ET in
humans. Importantly, however, rs2244352 falls within the
boundaries of a TAD that, in addition to WRB, includes LCA5L,
SH3BGR, HMGN1, BRWD1, and PSMG1 (Fig. 2B; Supplemen-
tary Table S9). Thus, it remains possible that the susceptibility to
ET is mediated through the action of rs2244352 on the
regulation of one or more of these other genes.
The associated SNP rs2244352 maps to chromosome
21q22.2 within the Down syndrome critical region,59–61 and
individuals with Down syndrome have a much higher (~20%)
incidence of ET compared to the general population.62,63 Thus,
it is possible that inheritance of a third copy of chromosome 21
increases expression of WRB and/or nearby genes and
contributes to the ET found in this patient population.
WRB is a maternally imprinted gene; the maternal allele is
methylated and silenced while the paternal allele is unmethy-
lated and expressed.47–49 It is known that the effects of
methylation on gene expression can vary with tissue and
developmental stage,64,65 that imprinted genes often function
as developmental regulators,66 and that genomic imprinting
can contribute to complex traits.67–70 Consistent with this, we
found a paternal skew in the inheritance of the rs2244352 [T]
allele in cases of nonaccommodative ET. These findings suggest
that paternal inheritance of the at-risk allele increases WRB
expression in the critical tissue(s) and at the critical
developmental timepoint(s) to enhance susceptibility to non-
accommodative ET. Moreover, WRB is the only gene in the TAD
demonstrated to be maternally imprinted,48,49 adding strength
to the hypothesis that WRB is the gene providing susceptibility
to nonaccommodative ET. While our data support a protective
effect of the maternal allele, additional studies would be
required to confirm this finding.
Methylation status is known to be influenced by the
environment; and the specific environmental factors that
correlate with increased risk of developmental strabismus,
including maternal smoking, advanced maternal age, and
premature birth,22,23,71–73 have been found to also alter the
offspring’s methylation status.74–76 Among these, a meta-
analysis has specifically identified reduced methylation of
WRB in offspring of mothers who smoked during pregnancy,77
raising the possibility that genetic and epigenetic influences
are working through a common pathway to increase the risk of
developmental strabismus.
Future studies of additional developmental strabismus
cohorts are necessary to further replicate the significance of
rs2244352 among White European individuals with nonaccom-
modative ET, determine if it contributes to ET among other
ethnicities, and confirm its potential imprinting. These studies
will help to establish whether a specific ET subtype primarily
drives the signal, and determine if this SNP may also provide
susceptibility to XT. Additional studies are also necessary to
determine if rs2244352 or a different SNP in high LD with
rs2244352 is the causative SNP, and whether altered expression
of WRB or another gene in the region is responsible for the
increased risk of nonaccommodative ET. Finally, larger studies
are necessary to determine if rs912759 replicates in accommo-
dative ET, and to determine if any of the additional SNPs
identified in either the nonaccommodative and accommodative
cohorts that were suggestive of association are truly significant.
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